The Conversation reports cataract surgery is safe and common, with over 90% achieving 20/20 vision, but patients need to ...
FDA IND clearance enables a phase 3 program evaluating TRIESENCE for postoperative ocular inflammation and pain following cataract surgery, aiming to broaden on-label use beyond current intraocular ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results